Abbott's PLEX-ID
This article was originally published in The Gray Sheet
Executive Summary
Abbott anticipates a CE-mark approval later this year for its new PLEX-ID system for detecting and characterizing a wide range of pathogens, including infectious agents commonly transmitted in hospitals. The system, the next generation of Abbott's Ibis T5000 Biosensor System, combines PCR amplification with mass spectrometry and will provide results in six to seven hours instead of three or more days, Abbott says